Abstract
Objective:
The metabolic syndrome is associated with increased risk for cardiovascular disease and diabetes. Several analyses from the Atherosclerosis Risk in Communities (ARIC) study have been performed to examine the role of the metabolic syndrome and its components in predicting risk for cardiovascular disease and diabetes.
Design and subjects:
The large, biracial, population-based ARIC study enrolled 15 792 middle-aged Americans in four communities in the United States and has followed them for the development of cardiovascular disease and diabetes.
Measurements:
Outcome parameters included prevalence of the metabolic syndrome and its individual components, carotid intima-media thickness, incident coronary heart disease, incident ischemic stroke and incident diabetes.
Results and conclusion:
Several analyses from the ARIC study have shown that the metabolic syndrome, as well as individual metabolic syndrome components, is predictive of the prevalence and incidence of coronary heart disease, ischemic stroke, carotid artery disease and diabetes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.
National Cholesterol Education Program. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143–3421.
Ford ES, Giles WH, Mokdad AH . Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004; 27: 2444–2449.
ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989; 129: 687–702.
McNeill AM, Rosamond WD, Girman CJ, Heiss G, Golden SH, Duncan BB et al. Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study). Am J Cardiol 2004; 94: 1249–1254.
McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 2005; 28: 385–390.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735–2752.
Schmidt MI, Duncan BB, Bang H, Pankow JS, Ballantyne CM, Golden SH et al. Identifying individuals at high risk for diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2005; 28: 2013–2018.
Schmidt MI, Duncan BB, Vigo A, Pankow J, Ballantyne CM, Couper D et al., for the ARIC Investigators. Detection of undiagnosed diabetes and other hyperglycemia states: the Atherosclerosis Risk in Communities Study. Diabetes Care 2003; 26: 1338–1343.
Mosca L, Linfante AH, Benjamin EJ, Berra K, Hayes SN, Walsh BW et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 2005; 111: 499–510.
Acknowledgements
The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021 and N01-HC-55022. Additional funding for this study was provided by National Institute of Diabetes and Digestive and Kidney Diseases Grant RO1-DK56918. We thank the staff and participants of the ARIC study for their important contributions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ballantyne, C., Hoogeveen, R., McNeill, A. et al. Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study. Int J Obes 32 (Suppl 2), S21–S24 (2008). https://doi.org/10.1038/ijo.2008.31
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2008.31
Keywords
This article is cited by
-
Handlungsempfehlungen zur individuellen Risikoermittlung von Komorbidität bei erwachsenen Patienten mit Psoriasis
Die Dermatologie (2023)
-
Effects of fetal famine exposure on the cardiovascular disease risk in the metabolic syndrome individuals
Diabetology & Metabolic Syndrome (2022)
-
The interaction between metabolic syndrome and physical activity, and risk for gestational diabetes mellitus
Acta Diabetologica (2021)
-
Elucidating the Multidimensionality of Socioeconomic Status in Relation to Metabolic Syndrome in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
International Journal of Behavioral Medicine (2020)
-
Changes in body composition and metabolic disease risk
European Journal of Clinical Nutrition (2019)